begin privacyenhanced message proctype 2001micclear originatorname webmasterwwwsecgov originatorkeyasymmetric mfgwcgyevqgbaqicaf8dsgawrwjaw2snkk9avtbzyzmr6agjlwyk3xmzv3dtinen twsm7vrzladbmyqaionwg5sdw3p6oam5d3tdezxmm7z1tbtwidaqab micinfo rsamd5rsa kl3uwzncp1lsqhuflesyrgks3t0sbtto67arkbh6fbkwqpt698lcofl8yej5m afxags2dg28lmrm7wkpnmq 000095012310021701txt 20100305 000095012310021701hdrsgml 20100305 20100305172630 accession number 000095012310021701 conformed submission type sc 14d9a public document count 2 filed date 20100305 date change 20100305 subject company company data company conformed name global med technology inc central index key 0001009463 standard industrial classification servicesprepackaged software 7372 irs number 841116894 state incorporation co fiscal year end 1231 filing value form type sc 14d9a sec act 1934 act sec file number 00554591 film number 10661756 business address street 1 12600 w colfax street 2 suite c420 city lakewood state co zip 80215 business phone 3032382000 mail address street 1 12600 west colfax avenue street 2 suite c420 city lakewood state co zip 801253737 former company former conformed name global data technology inc date name change 19960808 filed by company data company conformed name global med technology inc central index key 0001009463 standard industrial classification servicesprepackaged software 7372 irs number 841116894 state incorporation co fiscal year end 1231 filing value form type sc 14d9a business address street 1 12600 w colfax street 2 suite c420 city lakewood state co zip 80215 business phone 3032382000 mail address street 1 12600 west colfax avenue street 2 suite c420 city lakewood state co zip 801253737 former company former conformed name global data technology inc date name change 19960808 sc 14d9a 1 g22398sc14d9zahtm sc 14d9a sc14d9za united state security exchange commission washington dc 20549 schedule 14d9 solicitationrecommendation statement section 14d4 security exchange act 1934 amendment no 1 global med technology inc name subject company global med technology inc name person filing statement common stock par value 001 per share series convertible preferred stock par value 001 per share title class security 37935e101 cusip number class security michael i ruxin chief executive officer global med technology inc 12600 west colfax suite c420 lakewood co 80215 303 2382000 name address telephone number person authorized receive notice communication behalf person filing statement copy to clayton e parker martin t schrier kl gate llp 200 s biscayne boulevard suite 3900 miami florida 33131 305 5393300 check box filing relates solely preliminary communication made commencement tender offer amendment no 1 solicitationrecommendation statement schedule 14d9 amends supplement solicitationrecommendation statement schedule 14d9 filed global med technology inc colorado corporation “global med” security exchange commission the “sec” march 4 2010 a amended supplemented time time “schedule 14d9” schedule 14d9 relates offer haemonetics corporation massachusetts corporation “haemonetics” wholly owned subsidiary atlas acquisition corp colorado corporation “purchaser” purchase outstanding share global med’s common stock 001 par value per share the “global med common stock” outstanding share global med’s series convertible preferred stock 001 par value per share the “global med preferred stock” upon term subject condition set forth haemonetics’ offer purchase dated february 19 2010 a amended supplemented time time “offer purchase” offer purchase attached exhibit a1a schedule filed haemonetics sec february 19 2010 a amended supplemented time time “schedule to” term offer a defined below set forth offer purchase related letter transmittal global med common stock letter transmittal global med preferred stock each context requires “letter transmittal” together offer purchase “offer” capitalized term used otherwise defined herein shall respective meaning ascribed term schedule 14d9 item 9 exhibit item 9 schedule 14d9 hereby amended supplemented adding following a10 letter former shareholder inlog sa dated march 5 2010 signature due inquiry best knowledge belief certify information set forth statement true complete correct global med technology inc by s michael i ruxin md name michael i ruxin md title chief executive officer dated march 5 2010 ex99a10 2 g22398exv99waw10htm ex99a10 exv99waw10 exhibit a10 global med technology inc 12600 west colfax suite c420 lakewood colorado 80215 re limited waiver lockup lady gentleman january 31 2010 global med technology inc “global med” entered agreement plan merger the “merger agreement” haemonetics corporation massachusetts corporation “parent” atlas acquisition corp colorado corporation whollyowned subsidiary parent “acquisition sub” term merger agreement acquisition sub commence tender offer share global med’s common stock par value 001 per share “global med common stock” price 122 per share net holder global med common stock share global med’s series convertible preferred stock par value 001 per share “global med preferred stock” price 122 per share converted global med common stock basis net holder global med preferred stock cash the “offer” merger agreement provides subject certain condition commencement offer promptly reasonably practicable date merger agreement following consummation offer subject satisfaction waiver condition set forth merger agreement acquisition sub merge global med the “merger” global med shall continue surviving corporation section 71b certain stock purchase agreement dated march 26 2008 global med renaud blancbernard guillaume jacob olivier gaydon philippe blain david rigaud thierry charvin nathalie bonvalot christine salf peter heussner mordicus alfirin rb2 conseil parfiges amended the “inlog stock purchase agreement” provides seller a defined inlog stock purchase agreement subject certain condition exception agreed sell transfer grant option otherwise dispose together “dispose of” agree dispose share global med common stock issued pursuant section 22 inlog stock purchase agreement the “shares” period five 5 year global med hereby grant limited waiver section 71b inlog stock purchase agreement seller solely allow seller tender share acquisition sub offer dispose share merger case subject term limitation condition offer february 23 2010 page 2 important additional information filed security exchange commission waiver letter neither offer purchase solicitation offer sell share global med atlas acquisition corp filed tender offer statement sec february 19 2010 mailed offer purchase form letter transmittal related document global med shareholder document contain important information tender offer global med shareholder urged carefully read document document relating tender offer filed sec document available charge sec’s website wwwsecgov copy may also obtained free directing request df king co inc 48 wall street new york new york 10005 18005496697 truly yours s michael i ruxin md michael i ruxin md chief executive officer cc clayton e parker esq martin schrier esq lisa haddad esq end privacyenhanced message